Get the tools used by (smart)2 investors.

Total Debt for Vyne Therapeutics Inc

Join now and get access to the full platform

Search for company or ETF

 

  0 results available. Select is focused ,type to refine list, press Down to open the menu,

VYNE: Vyne Therapeutics Inc

VYNE Therapeutics Inc., a clinical-stage biopharmaceutical company, focuses on developing therapies to treat chronic inflammatory and immune-mediated conditions. The company’s lead program is repibres...

1.55 USD
Price
USD
Fair Value
Upside
1.44 - 4.30
52-week range

Analysis

Fiscal Years
Trailing Twelve Months
Fiscal Halfs
Fiscal Quarters
Daily
Hide this widget

The following section summarizes insights on Vyne Therapeutics Inc's Total Debt:

Dec 2016Dec 2018Dec 2020Dec 2022Dec 20240 K10 M20 M30 M40 M

Performance Summary
  • Vyne Therapeutics's total debt last quarter was 99 thousand
  • Vyne Therapeutics's total debt for fiscal years ending December 2020 to 2024 averaged 7.089 million.
  • Vyne Therapeutics's operated at median total debt of 214 thousand from fiscal years ending December 2020 to 2024.
  • Looking back at the last 5 years, Vyne Therapeutics's total debt peaked in December 2020 at 34.784 million.
  • Vyne Therapeutics's total debt hit its 5-year low in December 2022 of zero.
  • Vyne Therapeutics's total debt decreased in 2021 (349 thousand, -99.0%), 2022 (zero, -100.0%), and 2024 (99 thousand, -53.7%) and increased in 2020 (34.784 million, +0.9%) and 2023 (214 thousand, NA).

How does Vyne Therapeutics's Total Debt benchmark against competitors?

Hide this widget

Metric Usage: Total Debt

Hide this widget
total_debt
Slug
number
Datatype
text
Format
current
Default Period
FY, Q
Periods Supported
Free
Plan

To view the full list of supported financial metrics please see Complete Metrics Listing.

Similar Metrics

Hide this widget

Metrics similar to Total Debt in the financials category include:

  • Deferred Charges, Current - A current asset arising from costs that have been paid where the benefits are deferred to a later date.
  • Revenue - The revenue metric captures the total income generated by a company from its core operational activities
  • Real Estate Owned - Real estate and other properties reported separately from other plant, property and equipment fields.
  • Other Non Operating Income (Expenses) - This item represents any other income (expense), which is not directly attributable to the operating activities of the company.
View Full List

Search for metric or datapoint

Total Debt

The sum of all debt and capital lease obligations.

Definition of Total Debt

Hide this widget

VYNE Therapeutics reported total debt of 99 T for the latest quarter ending December 31, 2024 on its balance sheet.

The tables below summarizes VYNE Therapeutics’s Total Debt and common size over the last five years:

Fiscal YearTotal DebtAssets% Assets
2020-12-3134.784 M93.742 M37.1%
2021-12-31349 T67.046 M0.5%
2022-12-31zero40.758 M0.0%
2023-12-31214 T97.685 M0.2%
2024-12-3199 T66.905 M0.1%

The tables below summarizes VYNE Therapeutics’s Total Debt and common size over the last four quarters:

Quarter EndingTotal DebtAssets% Assets
2024-03-31180 T91.676 M0.2%
2024-06-30145 T86.648 M0.2%
2024-09-30123 T76.198 M0.2%
2024-12-3199 T66.905 M0.1%

Click the link below to download a spreadsheet with an example Total Debt calculation for Vyne Therapeutics Inc below:

Sector Benchmark Analysis

Sector
Industry Group
Industry
Hide this widget
0 K3 B6 B10.885 B05001,0001,5002,000

The chart above depicts the distribution of total debt for companies operating in the Healthcare sector in the Developed economic region. Over 2,465 companies were considered in this analysis, and 2,422 had meaningful values. The average total debt of companies in the sector is 255 M with a standard deviation of 1.033 B.

Vyne Therapeutics Inc's Total Debt of 99 K ranks in the 16.1% percentile for the sector. The following table provides additional summary stats:

Total Debt In The Healthcare Sector
Economic Risk RegionDeveloped
Total Constituents2,470
Included Constituents2,422
Min0 K
Max10.671 B
Median6.169 M
Mean255 M
Standard Deviation1.033 B

You can find companies with similar total debt using this stock screener.

All rights reserved. Terms Of Use